Cardlytics, Inc. CDLX
Set alert
2.08 USD +0.30 +16.57%
At close · Nov 2
2.08 0.00 +0.24%
After hours · Nov 2, 6:36 PM ET
1.78 Day range 2.20
1.57 52-week range 19.50
- YTD
- -81.96%
- 1 year
- -89.30%
- Open
- 1.80
- Prev close
- 1.78
- Mkt cap
- 12.22M
- Vol
- 215.27K
- Avg vol
- 57.55K
- EPS
- -18.99
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.78
- High
- 2.20
- Forward P/E
- -11.35
- Beta
- 1.62
- Short ratio
- 7.61
- Inst. own
- 61.50%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 3.93
- 200-d avg
- 7.26
- 1y target
- 4.40
3M chart
Signals (11)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
Financial health
Altman Z-Score
-8.80 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.6×
FY 2016 5y median -0.9× FY 2025
P/S 0.3×
FY 2016 5y median 0.6× FY 2025
P/B -9.4×
FY 2016 5y median 2.5× FY 2025
P/FCF -9.4×
FY 2016 5y median -9.4× FY 2025
EV/EBITDA -3.5×
FY 2016 5y median -3.5× FY 2025
EV/Sales 1.0×
FY 2016 5y median 1.2× FY 2025
FCF Yield -10.6%
FY 2016 5y median -10.6% FY 2025
Profitability
Gross Margin 45.0%
FY 2016 5y median 42.2% FY 2025
Operating Margin -20.2%
FY 2016 5y median -45.9% FY 2025
Net Margin -44.4%
FY 2016 5y median -48.1% FY 2025
ROE 1590.2%
FY 2016 5y median -99.9% FY 2025
ROIC -22.6%
FY 2016 5y median -33.5% FY 2025
ROA -36.2%
FY 2016 5y median -36.2% FY 2025
Growth (YoY)
Revenue -16.2%
FY 2016 FY 2025
Operating Income 75.9%
FY 2016 FY 2025
EPS (diluted) 50.1%
FY 2016 FY 2025
Free Cash Flow 76.9%
FY 2016 FY 2025
Financial Health
Current Ratio 1.8×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 1.8×
FY 2016 5y median 1.2× FY 2025
Debt / Equity -33.1×
FY 2016 5y median 1.1× FY 2025
Net Debt / EBITDA -2.5×
FY 2016 5y median -1.0× FY 2025
Interest Coverage -4.4×
FY 2016 5y median -21.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
